BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Impact of a Gastrointestinal Stable Probiotic Supplement Bacillus coagulans LBSC on Human Gut Microbiome Modulation. ✅
Go to Publication ✅
Journal of dietary supplements (J Diet Suppl ) Vol: Issue Pages: 1-20 Pub: 2020 Sep 8 Epub: 2020 Sep 8 Authors Maity C , Gupta AK , Saroj DB , Biyani A , Bagkar P , Kulkarni J , Dixit Y , |
|
|
Orange Juice and Yogurt Carrying Probiotic Bacillus coagulans GBI-30 6086: Impact of Intake on Wistar Male Rats Health Parameters and Gut Bacterial Diversity. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 12 Issue Pages: 623951 Pub: 2021 Epub: 2021 Apr 1 Authors Almada-Érix CN , Almada CN , Cabral L , Barros de Medeiros VP , Roquetto AR , Santos-Junior VA , Fontes M , Gonçalves AESS , Dos Santos A , Lollo PC , Magnani M , Sant`Ana AS , |
|
|
Spore-forming Bacillus coagulans SNZ 1969 improved intestinal motility and constipation perception mediated by microbial alterations in healthy adults with mild intermittent constipation: A randomized controlled trial. ✅
Go to Publication ✅
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 146 Issue Pages: 110428 Pub: 2021 Aug Epub: 2021 May 19 Authors Kang S , Park MY , Brooks I , Lee J , Kim SH , Kim JY , Oh B , Kim JW , Kwon O , |
|
|
Effects of Bacillus coagulans TBC169 on gut microbiota and metabolites in gynecological laparoscopy patients. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1284402 Pub: 2024 Epub: 2024 Mar 26 Authors Gao W , Yan Y , Guan Z , Zhang J , Chen W , |
|
|
Probiotic modulation of gut microbiota by Bacillus coagulans MTCC 5856 in healthy subjects: A randomized, double-blind, placebo-control study. ✅
Go to Publication ✅
Medicine (Medicine (Baltimore) ) Vol: 102 Issue 20 Pages: e33751 Pub: 2023 May 19 Epub: Authors Majeed M , Nagabhushanam K , Mundkur L , Paulose S , Divakar H , Rao S , Arumugam S , |
|
|
Probiotic modulation of gut microbiota by Bacillus coagulans MTCC 5856 in healthy subjects: A randomized, double-blind, placebo-control study. ✅
Go to Publication ✅
Medicine (Medicine (Baltimore) ) Vol: 102 Issue 20 Pages: e33751 Pub: 2023 May 19 Epub: Authors Majeed M , Nagabhushanam K , Mundkur L , Paulose S , Divakar H , Rao S , Arumugam S , |
|
|
Bacillus coagulans (Weizmannia coagulans) XY2 attenuates Cu-induced oxidative stress via DAF-16/FoxO and SKN-1/Nrf2 pathways and gut microbiota regulation. ✅
Go to Publication ✅
Journal of hazardous materials (J Hazard Mater ) Vol: 457 Issue Pages: 131741 Pub: 2023 Sep 5 Epub: 2023 Jun 1 Authors Gao Y , Yu T , Wu Y , Huang X , Teng J , Zhao N , Zheng X , Yan F , |
|
|
Bacillus coagulans (Weizmannia coagulans) XY2 attenuates Cu-induced oxidative stress via DAF-16/FoxO and SKN-1/Nrf2 pathways and gut microbiota regulation. ✅
Go to Publication ✅
Journal of hazardous materials (J Hazard Mater ) Vol: 457 Issue Pages: 131741 Pub: 2023 Sep 5 Epub: 2023 Jun 1 Authors Gao Y , Yu T , Wu Y , Huang X , Teng J , Zhao N , Zheng X , Yan F , |
|
|
Effect of Probiotic Product Containing Heyndrickxia coagulans TBC169 on Hyperuricemia in Rats. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2025 Mar 24 Epub: 2025 Mar 24 Authors Duan L , Zhang X , Wang D , Xin J , Jiang Y , Sun N , Chen B , Luo J , He Y , Pan K , Zeng Y , Jing B , Ni X , Liu H , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
